Float Short %

11.81

Margin Of Safety %

Put/Call OI Ratio

0.22

EPS Next Q Diff

-0.06

EPS Last/This Y

0.92

EPS This/Next Y

0.81

Price

1.79

Target Price

5.6

Analyst Recom

2.38

Performance Q

-31.68

Upside

-4,753.6%

Beta

2.2

Ticker: EDIT

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-01-23	EDIT	2.15	0.12	0.44	20803
2026-01-26	EDIT	2.07	0.13	7.77	20925
2026-01-27	EDIT	2.11	0.17	0.14	22003
2026-01-28	EDIT	2.06	0.16	0.29	22308
2026-01-29	EDIT	2.07	0.16	0.72	22573
2026-01-30	EDIT	1.98	0.17	2.11	22745
2026-02-02	EDIT	2.02	0.19	2.08	23380
2026-02-03	EDIT	2.06	0.20	0.25	23596
2026-02-05	EDIT	1.66	0.20	1.34	24083
2026-02-09	EDIT	1.805	0.22	0.02	24730
2026-02-10	EDIT	1.79	0.22	1.00	24787
2026-02-11	EDIT	1.78	0.22	0.75	24789
2026-02-12	EDIT	1.67	0.22	0.06	24828
2026-02-13	EDIT	1.76	0.22	0.64	24809
2026-02-17	EDIT	1.73	0.23	9.49	24963
2026-02-18	EDIT	1.725	0.23	3.03	24955
2026-02-19	EDIT	1.81	0.23	9.89	25037
2026-02-20	EDIT	1.79	0.22	0.76	24902
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-01-23	EDIT	2.15	60.9	-	-1.96
2026-01-26	EDIT	2.07	60.9	-	-1.96
2026-01-27	EDIT	2.11	60.9	-	-1.96
2026-01-28	EDIT	2.06	60.9	-	-1.96
2026-01-29	EDIT	2.07	60.9	-	-1.96
2026-01-30	EDIT	1.98	60.9	-	-1.96
2026-02-02	EDIT	2.02	60.9	-	-1.96
2026-02-03	EDIT	2.06	60.9	-	-1.96
2026-02-04	EDIT	1.96	60.9	-	-1.96
2026-02-05	EDIT	1.66	60.9	-	-1.96
2026-02-06	EDIT	1.81	60.9	-	-1.96
2026-02-09	EDIT	1.81	60.9	-	-1.96
2026-02-10	EDIT	1.79	60.9	-	-1.96
2026-02-11	EDIT	1.78	60.9	-	-1.96
2026-02-12	EDIT	1.67	60.9	-	-1.96
2026-02-13	EDIT	1.75	60.9	-	-1.96
2026-02-17	EDIT	1.73	60.9	-	-1.96
2026-02-18	EDIT	1.73	60.9	-	-1.96
2026-02-19	EDIT	1.80	60.9	-	-1.96
2026-02-20	EDIT	1.79	60.9	-	-1.96
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-01-23	EDIT	-3.74	2.08	11.66
2026-01-26	EDIT	-3.74	2.09	11.66
2026-01-27	EDIT	-3.74	2.09	11.66
2026-01-28	EDIT	-3.74	2.09	12.18
2026-01-29	EDIT	-3.74	2.09	12.18
2026-01-30	EDIT	-3.74	2.09	12.18
2026-02-02	EDIT	-3.74	2.08	12.18
2026-02-03	EDIT	-3.74	2.08	12.18
2026-02-04	EDIT	-3.74	2.08	12.18
2026-02-05	EDIT	-2.78	2.08	12.18
2026-02-06	EDIT	-2.78	2.08	12.18
2026-02-09	EDIT	-2.65	4.32	12.18
2026-02-10	EDIT	-2.65	4.32	12.18
2026-02-11	EDIT	-2.65	4.32	11.80
2026-02-12	EDIT	-2.65	4.32	11.80
2026-02-13	EDIT	-2.65	4.32	11.80
2026-02-17	EDIT	-2.65	7.98	11.80
2026-02-18	EDIT	-2.65	7.98	11.80
2026-02-19	EDIT	-2.65	7.98	11.80
2026-02-20	EDIT	-2.65	7.98	11.81
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.28

Avg. EPS Est. Current Quarter

-0.21

Avg. EPS Est. Next Quarter

-0.34

Insider Transactions

-2.65

Institutional Transactions

7.98

Beta

2.2

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

97.6

Max Drawdown 5-Year %

-98.7

Target Price

5.6

P/E

Forward P/E

PEG

P/S

3.77

P/B

12.41

P/Free Cash Flow

EPS

-2.38

Average EPS Est. Cur. Y

-1.96

EPS Next Y. (Est.)

-1.14

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-430.84

Relative Volume

0.9

Return on Equity vs Sector %

-1514.4

Return on Equity vs Industry %

-1497

EPS 1 7Days Diff

EPS 1 30Days Diff

0.05

EBIT Estimation

Editas Medicine, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 246

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

stock quote shares EDIT – Editas Medicine, Inc. Stock Price stock today

news today EDIT – Editas Medicine, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch EDIT – Editas Medicine, Inc. yahoo finance google finance

stock history EDIT – Editas Medicine, Inc. invest stock market

stock prices EDIT premarket after hours

ticker EDIT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: EDIT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y